ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,529,880 | -35.8% | 228,000 | -15.6% | 4.32% | -27.9% |
Q1 2023 | $2,384,100 | +7.7% | 270,000 | -6.8% | 6.00% | -7.1% |
Q4 2022 | $2,213,507 | +7.3% | 289,726 | 0.0% | 6.45% | +89.3% |
Q3 2022 | $2,063,000 | +34.4% | 289,726 | +52.7% | 3.41% | -17.9% |
Q2 2022 | $1,535,000 | -26.0% | 189,726 | +211.0% | 4.15% | +332.5% |
Q3 2021 | $2,073,000 | -79.4% | 61,000 | -75.2% | 0.96% | -56.9% |
Q2 2021 | $10,060,000 | -20.9% | 246,200 | -22.1% | 2.23% | -28.0% |
Q1 2021 | $12,722,000 | – | 316,000 | – | 3.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |